Crohn's disease (CD) is a polygenic immune-mediated disease characterized by gastrointestinal inflammation. Mice deficient in the hematopoietic-restricted SH2 domain-containing inositolpolyphosphate 5′-phosphatase (SHIP) develop spontaneous CD-like ileal inflammation. Intriguingly, SHIP mRNA is not upregulated in biopsies from patients with ileal CD despite immune cell infiltration, but SHIP's role in human CD remains unknown. We analyzed SHIP mRNA expression and activity in biopsies and peripheral blood mononuclear cells (PBMCs) from control and treatment-naive subjects with ileal CD, and demonstrated that SHIP mRNA and activity were lower in hematopoietic cells in ileal biopsies and PBMCs from subjects with CD. In all tissues from our patient cohort and in PBMCs from a second healthy control cohort, subjects homozygous for the autophagy-related 16-like protein (ATG16L1) CDassociated gene variant (rs2241880), had low SHIP mRNA expression and activity. SHIP protein expression increased during autophagy and SHIP upregulation was dependent on ATG16L1 and/or autophagy, as well as the ATG16L1 CD-associated gene variant. Finally, homozygosity for the ATG16L1 risk variant and low SHIP mRNA expression is inversely related to increased (LPS +ATP)-induced IL-1β production by PBMCs in our cohorts and was regulated by increased transcription of ILIB. These data suggest a novel mechanism by which the ATG16L1 CD-associated gene variant may predispose people to develop intestinal inflammation.
INTRODUCTION
Crohn's disease (CD) is a chronic inflammatory disease characterized by intestinal inflammation that can occur anywhere along the gastrointestinal tract. 1 The most common site for inflammation is the distal part of the ileum. 1 The interactions between genetic and environmental factors, 2 intestinal microbes and the epithelial lining, as well as the immune system are believed to be crucial for the development of chronic inflammation during CD. 3 Genome-wide association studies have identified 163 susceptibility loci associated with inflammatory bowel disease (IBD), 140 of which are associated with CD. 2 A non-synonymous single nucleotide polymorphism (SNP) in the gene encoding the autophagy-related 16-like protein (ATG16L1) has been associated with increased risk for developing CD in multiple populations [4] [5] [6] [7] and specifically with the development of ileal CD. 8 The ATG16L1 CD-associated gene variant is common in the population with 33.2% of people from Western European descent being homozygous for the risk variant. 9 People, who have one copy of the ATG16L1 CD-associated gene variant, have a 1.86-fold increased risk of developing CD by (95% confidence interval 1.09-3.24) and people, who have two copies of the ATG16L1 risk allele, have a 2.38-fold increased risk of developing CD (95% confidence interval 1.40-4.04) thus the effect of this risk allele is gene-dose dependent. 10 The ATG16L1 risk allele codes for a threonine to alanine amino-acid substitution at position 300 in the ATG16L1 protein (T300A). 8 ATG16L1 is crucial for autophagy, a multistep, catabolic self-preservation process that controls clearance and reuse of intracellular components during homeostasis and provides amino acids required for cell survival under stress conditions including starvation, accumulation of unfolded proteins, or intracellular infection. 11 ATG16L1 sets the platform for recruitment of the ATG12-ATG5 complex to the immature phagophore membrane, which in turn permits progression and closure of the membrane to form the autophagosome. 12 ATG16L1 deficiency in mice or homozygosity for the ATG16L1 CD-associated gene variant in humans causes defects in Paneth cell granule exocytosis, 13 which may be important in susceptibility to disease in response to specific infections and/or environmental influences. 14 Moreover, CD patients, who are homozygous for the ATG16L1 CD risk allele, are unable to adequately clear pathosymbionts and monocytes from subjects with the ATG16L1 T300A risk protein have impaired ability to clear invading pathogens. 15 In humans, defects in autophagy and the ATG16L1 risk variant have been associated with increased IL-1β production. [16] [17] [18] IL-1β is a critical cytokine, which can be produced by monocytes and macrophages to initiate and amplify the innate immune responses. 19 Thus, its production is tightly regulated by a twostep process. First, innate immune stimuli induce transcription of IL1B, which is translated to pro-IL-1β, an inactive precursor. Second, danger-associated molecular patterns cause assembly of the inflammasome activating caspase-1, which cleaves pro-IL-1β, leading to activation and secretion of mature IL-1β. [20] [21] [22] The ATG16L1 T300A protein has recently been shown to be cleaved by caspase 3/7, resulting in defective autophagic control of intracellular bacteria and increased IL-1β secretion. 16, 17 Consistent with these results, peripheral blood mononuclear cells (PBMCs) from patients, who are homozygous for ATG16L1 risk variant, produce more IL-1β in response to muramyl dipeptide than those from subjects, who are homozygous for the variant that is not associated with CD. 18 Moreover, differences observed were attributed to increased ILIB transcription. 18 In mice, increased IL-1β production associated with autophagy defects has been attributed to increased inflammasome activity, but the molecular mechanism(s) by which autophagy and/or ATG16L1 regulate ILIB transcription in humans remains unknown.
The SH2 domain-containing inositolpolyphosphate 5′-phosphatase (SHIP) is a hematopoietic-specific lipid phosphatase that negatively regulates class I phosphatidylinositol 3-kinase (PI3K) activity. SHIP antagonizes class I PI3K signaling by dephosphorylating the 5′ position of class I PI3K-generated phosphatidylinositol 3,4,5 trisphosphate (PI(3,4,5)P 3 ). Class I PI3K is critical in many cellular processes including immune activation, thus, SHIPdeficient mice are hyperresponsive to immune stimuli, [23] [24] [25] [26] including increased IL-1β production in response to innate immune activation. 24 We, and others, have reported that SHIPdeficient mice develop spontaneous CD-like intestinal inflammation that is primarily restricted to the distal ileum. 26, 27 In humans, SHIP mRNA expression is increased in inflamed colonic biopsies from people with ulcerative colitis and colonic CD, which is consistent with dramatic immune cell infiltration into tissues during inflammation and SHIP expression being restricted to hematopoietic cells. 28 More surprisingly, SHIP mRNA expression was not elevated in inflamed biopsies from subjects with ileal CD. 28 The human gene encoding SHIP protein (INPP5D) is located at chromosome 2q37.1 and is 40 kb upstream of the gene encoding ATG16L1. 29 INPP5D and ATG16L1 are located on the same DNA strand and are transcribed in the same direction. Though there are SNPs in ATG16L1, which are in linkage disequilibrium with rs2241880, 30 there are no SNPs in INPP5D, which co-segregate with rs2241880.
Humans carrying the ATG16L1 risk variant and mice deficient in SHIP have increased susceptibility to CD or ileal inflammation, respectively, and their macrophages have increased ability to produce IL-1β. Thus, we asked whether SHIP mRNA expression and activity are regulated by ATG16L1 and whether SHIP may contribute to increased IL-1β production in subjects with the ATG16L1 risk variant. Herein, we report that SHIP mRNA expression was reduced in subjects with ileal CD. In our patient cohort and a second cohort of healthy control subjects, both SHIP mRNA expression and activity levels were extremely low in subjects, who were homozygous for the ATG16L1 T300A-encoding risk allele. Furthermore, we show that autophagy upregulated SHIP protein and that SHIP upregulation was dependent on ATG16L1 protein levels and/or autophagy, and the ATG16L1 gene variant. Finally, we demonstrate that the ATG16L1 genotype and low SHIP mRNA expression were related to increased IL-1β production by (LPS +ATP)-stimulated PBMCs, and was dependent, at least in part, on IL1B transcription. Taken together, these results identify SHIP as a critical link between the ATG16L1 CD-associated gene variant and increased IL1B transcription, which may contribute to increased risk of developing intestinal inflammation.
RESULTS AND DISCUSSION
SHIP mRNA expression is reduced in subjects with ileal CD Previous studies from our laboratory, and others, have shown that SHIP-deficient mice develop spontaneous intestinal inflammation with similar features to human CD. 26, 27 Subsequent studies demonstrated that SHIP mRNA is not upregulated in ileal biopsies from people with ileal CD, 28 despite the fact that SHIP is hematopoietic restricted and there is a dramatic immune cell infiltration into the ileum during ileal CD. Based on that, we asked whether SHIP mRNA expression was reduced in immune cells from subjects with ileal CD compared with control subjects (C), who did not have IBD. Ileal and colonic biopsies and peripheral blood were collected from 21 treatment-naive subjects, who were undergoing colonoscopy as part of their diagnosis. Subjects were subsequently diagnosed with ileal CD (CD = 8) or were control subjects, who were not diagnosed with IBD (C = 13). Relative gene expression for genes encoding SHIP (INPP5D), CD45 (PTPRC, a hematopoietic cell marker) and β-actin (ACTB) were measured. SHIP mRNA expression was reduced in the ileum and colon, relative to PTPRC expression, and in PBMCs, relative to ACTB, from subjects diagnosed with ileal CD compared with control subjects (Figure 1a ). SHIP mRNA expression in the ileum, colon and PBMCs was associated with SHIP activity in both control and CD groups with R 2 = 0.85, 0.83 and 0.92 (Po 0.0001), respectively ( Figure 1b) .
These data confirm that SHIP mRNA is not upregulated in the ileum during ileal CD, as previously reported. 28 We extend that finding, demonstrating that SHIP mRNA expression is actually decreased during ileal CD, when normalized to infiltrating immune cells, and that reduced SHIP mRNA expression correlates with reduced SHIP activity. SHIP mRNA expression may be upregulated maintaining SHIP protein levels and activity in the colon, but not the ileum, due to higher abundance of commensal microorganisms in the colon 31 as SHIP mRNA and protein are induced by MyD88-dependent Toll-like receptor signaling. 23, 24 Homozygosity for the ATG16L1 T300A-encoding gene variant correlates with low SHIP mRNA expression and activity SHIP mRNA expression varied more than 10-fold in PBMCs from different subjects. Intriguingly, some subjects in both control and CD groups had very low SHIP mRNA expression and activity in all tissue samples, suggesting that there may be a genetic cause, which predisposes individuals to express low levels of SHIP mRNA. We next asked whether low SHIP mRNA and activity are correlated with the ATG16L1 genotype. As shown in Figure 2 , both SHIP mRNA expression ( Figure 2a ) and SHIP activity ( Figure 2b ) were significantly lower in biopsies from the ileum and colon and in PBMCs from all subjects (controls and CD), who were homozygous (GG) for the ATG16L1 CD susceptibility allele, compared to subjects, who were heterozygous (AG) or did not have the susceptibility allele (AA). There was no difference in SHIP mRNA expression or activity between subjects with the AA and AG genotypes.
To determine whether low SHIP mRNA expression and activity were independent of inflammation in CD, we recruited a second cohort of 18 healthy control subjects who were genotyped for the ATG16L1 SNP (rs2241880) (n = 6 subjects per genotype). We measured SHIP mRNA expression and activity in their PBMCs. Healthy control subjects, who were homozygous for the ATG16L1 CD susceptibility allele, had significantly lower SHIP mRNA expression ( Figure 3a ) and lower SHIP activity ( Figure 3b ) compared with the subjects, who did not have the susceptibility allele. SHIP mRNA expression and activity in subjects, who were heterozygous for the ATG16L1 genotype (AG), were not significantly different from the AA and GG groups (Figures 3a and b ).
In two independent cohorts, our results demonstrate that homozygosity for the ATG16L1 CD-associated gene variant was associated with low SHIP mRNA expression and activity. Moreover, the relationship between homozygosity for the ATG16L1 CD-associated gene variant and low SHIP mRNA and activity is independent of inflammation. In healthy control subjects, who were heterozygous for the SNP (AG genotype), SHIP mRNA expression and activity varied widely, ranging from low levels, comparable to that for people with the GG genotype, to high levels, comparable to that for people with the AA genotype. This suggests that additional environmental and/or genetic factors may contribute to low SHIP mRNA expression and activity in some individuals. SHIP protein levels are reduced by the type II inflammatory cytokines, IL-4 and IL-13. 32 In addition, 140 CD-associated risk variants have been identified, 2 including some that code for non-synonymous SNPs in proteins that cause autophagy defects (NOD2) 33 or that are predicted to affect autophagy (IRGM, ATG5, ORMDL3 and XBP-1). 2 SHIP and ATG16L1 are not transcriptionally co-regulated Low SHIP mRNA expression in subjects, who were homozygous for the ATG16L1 risk variant, suggested that SHIP (INPP5D) gene transcription may be co-regulated with ATG16L1 and expressed at lower levels in subjects, who were homozygous for the ATG16L1 risk allele. To investigate this possibility, we measured ATG16L1 gene expression in our subject cohorts. In our patient group, both control (C) and CD subjects had similar mRNA expression levels for ATG16L1 in intestinal tissues (Figure 4a , left), which did not vary linearly with SHIP mRNA expression (R 2 = 0.065; P = 0.356) (Figure 4a , right). Similarly, in our healthy control subject cohort, there was no difference in ATG16L1 mRNA expression in PBMCs from subjects with different ATG16L1 SNP genotypes (Figure 4b , left) and no relationship between ATG16L1 and SHIP mRNA expression (R 2 = 0.005; P = 0.812) (Figure 4b , right). These data are consistent with a previous report demonstrating that ATG16L1 mRNA expression is not influenced by the rs2241880 genotype. 4 This does not, however, preclude the possibility that SHIP gene expression may be reduced epigenetically by the presence of the ATG16L1 CD risk allele.
Starvation-induced autophagy upregulates SHIP protein, which is dependent on ATG16L1 or autophagy, and the risk allele genotype ATG16L1 is required for autophagy so we next asked whether autophagy affected SHIP protein levels. First, we compared SHIP protein levels during starvation-induced autophagy in murine MCSF-derived bone marrow macrophages from wild-type (SHIP +/+ ) and SHIP-deficient mice (SHIP − / − ). Intriguingly, SHIP protein levels were 4.3-fold higher during starvation-induced autophagy in macrophages from wild-type mice (Figure 5a , left, top panel). Also, in contrast to wild-type macrophages, SHIPdeficient macrophages did not express LC3-II protein upon starvation, a marker of autophagosome formation (Figure 5a , left, middle panel, lanes 2 and 5). In the presence of bafilomycin A1, which blocks autophagosome-lysosome fusion and flux through the autophagy pathway, LC3-II was detected in SHIP-deficient macrophages, albeit at lower levels than in comparably treated wild-type macrophages (Figure 5a , left, middle panel, lanes 3 and 6). To determine whether SHIP was transcriptionally upregulated during starvation-induced autophagy, SHIP mRNA expression was measured in wild type (SHIP +/+ ) murine bone marrow macrophages during starvation. SHIP mRNA expression was increased after 4 h in starvation medium (Figure 5a , right). It is intriguing to note that SHIP-deficient macrophages had a defect in starvationinduced autophagy. Class I PI3K is a negative regulator of autophagy 34 and rapamycin-mediated inhibition of mTOR, which is activated downstream of PI3K, is frequently used to induce autophagy. 35 Thus, SHIP may regulate autophagy in hematopoietic cells and increased SHIP expression may be required for the induction and/or maintenance of autophagy. In addition, a defect in autophagy could cause and/or contribute to the intestinal inflammation observed in SHIP-deficient mice. To determine whether SHIP was upregulated during autophagy in human cells, we compared SHIP protein levels during autophagy in PMA-differentiated THP-1 cells, a human myelomonocytic cell line. SHIP protein levels were induced 4.8-fold during starvation-induced autophagy in THP-1 cells (Figure 5b , left, 2nd panel). To determine whether ATG16L1 was required for autophagy-induced upregulation of SHIP protein, autophagy was induced by starvation in differentiated THP-1 cells in the presence of non-silencing RNA (nsRNA) or an siRNA construct targeting ATG16L1. The siRNA construct reduced ATG16L1 protein levels by 83% in untreated THP-1 cells (Figure 5b , left, top panel). Knockdown of ATG16L1 by siRNA was sufficient to block autophagy, indicated by reduced LC3-II expression, and blocked autophagy-induced upregulation of SHIP protein, whereas the control nsRNA had no effect (Figure 5b , left). As in bone marrowderived macrophages, SHIP protein induction by starvation correlated with increased SHIP mRNA expression in THP-1 cells. Moreover, siRNA targeting ATG16L1, which blocked SHIP protein induction, prevented SHIP mRNA induction during autophagy compared with the nsRNA control (Figure 5b, right) . Finally, we measured SHIP induction in response to starvation in PBMCs from six healthy control subjects with each ATG16L1 SNP genotype. genotype; AA, AG and GG. Average densitometry from six subjects in each group demonstrated that SHIP protein levels were 50% lower in subjects, who were homozygous for the ATG16L1 risk allele, compared with subjects, who did not have the risk allele (Figure 5c, right) . Together, these data demonstrate that SHIP mRNA and protein are upregulated during autophagy in three different cell models; murine bone marrow macrophages, a human myelomonocytic cell line, and in primary PBMCs from human subjects. Though SHIP induction is compromised during siRNA knockdown of ATG16L1 in THP-1 cells, it is not possible to distinguish whether this is caused by reduced ATG16L1 protein levels directly, or by diminished autophagy. Notably, SHIP protein levels are lower in PBMCs from subjects, who are homozygous for the ATG16L1 CD susceptibility genotype at steady state and upon induction of autophagy by starvation.
Homozygosity for the CD-associated ATG16L1 gene variant correlates with high IL-1β production and IL1B transcription The CD-associated ATG16L1 gene variant has been associated with defective autophagy 33 and high IL-1β production in response to NOD2 activation. 18 In a previous study, stimulation with muramyl dipeptide increased IL-1β and IL-6 in PBMCs from subjects, who carry the ATG16L1 risk variant. 18 Along with IL-1β and IL-6, TNFα is a critical cytokine that is upregulated and contributes to immune-mediated inflammation in CD. 36 Thus, we next measured the production of these pro-inflammatory cytokines in (LPS+ATP)stimulated PBMCs from control (C) and CD subjects as well as in our cohort of healthy control subjects, who were homozygous (GG), heterozygous (AG) or did not have the ATG16L1 T300A-encoding gene variant (AA). In our patient cohort, PBMCs from both control and CD subjects, who were homozygous for the ATG16L1 CD susceptibility gene variant, produced more IL-1β compared with subjects, who were heterozygous or did not carry the susceptibility allele (Figure 6a ). In contrast, there was no difference for TNFα or IL-6 production between the genotypes (Figure 6a ). In our second cohort of healthy control subjects, subjects who were homozygous (GG) for the ATG16L1 T300A-encoding gene variant, produced high levels of IL-1β compared with subjects, who were heterozygous (AG) or did not carry the risk variant (AA) (Figure 6b ). TNFα and IL-6 production were not affected by the ATG16L1 SNP genotype in healthy control subjects (Figure 6b ). Higher IL-6 production by PBMCs may be specific to muramyl dipeptide stimulation and/or may be induced downstream of IL-1β production. 37, 38 TNFα production was also not elevated in PBMCs from subjects, who carry the ATG16L1 risk variant, which may reflect differences in the signaling pathways required for TNFα versus IL-1β transcription. 39, 40 Production of both IL-6 and TNFα may be increased by PBMCs at later time points, downstream of IL-1β production. To determine whether increased transcription of ILIB contributes to increased IL-1β production by human PBMCs, IL1B transcription was measured in (LPS+ATP)stimulated PBMCs from healthy control subjects with each genotype. Healthy control subjects, who were homozygous (GG) or heterozygous (AG) for the ATG16L1 risk variant, had significantly higher IL-1β mRNA expression compared with subjects without the risk variant (AA) (Figure 6c ). There was no difference in IL-1β mRNA expression levels between subjects with AG and GG genotypes (Figure 6c ). Finally, we returned to our tractable cell models to determine whether SHIP mRNA and protein expression were inversely related to IL-1β production during autophagy. Wild type (SHIP +/+ ) bone marrow macrophages produced high levels of IL-1β upon stimulation with LPS+ATP, but their ability to produce IL-1β in response to stimulation was completely ablated when they were pre-incubated for 4 h in starvation medium to induce autophagy (Figure 6d ). In contrast, IL-1β production by (LPS+ATP)-stimulated THP-1 cells was only modestly reduced during autophagy (Figure 6e ). Similarly, there was a modest, but significant induction in IL-1β produced by THP-1 cells treated with siRNA to ATG16L1 compared with cells treated with nsRNA ( Figure 6e ). The lack of sensitivity of THP-1 cells to changes in their ability to produce IL-1β during autophagy may reflect an inherent change in these immortalized cells, which also had a high background for LC3-II staining, a marker of autophagosome formation (Figure 5b ). Despite that, SHIP mRNA expression and SHIP protein levels were inversely related to IL-β production by THP-1 cells, as they were in murine bone marrow macrophages and human PBMCs. SHIP mRNA expression is inversely related to high IL-1β production and IL1B transcription Next, we determined whether increased IL-1β production and IL1B transcription was associated with SHIP mRNA expression. Indeed, IL-1β production was inversely related to SHIP mRNA expression in (LPS+ATP)-stimulated PBMCs from control subjects (black circles) and subjects with CD (open squares; R 2 = 0.3723, P = 0.0033) (Figure 7a ). Similarly, in our second cohort of healthy control subjects, IL-1β production by (LPS+ATP)-stimulated PBMCs was inversely related to SHIP mRNA expression (R 2 = 0.4438, P = 0.0129) ( Figure 7b ) and IL1B transcription was also inversely related to SHIP mRNA expression (R 2 = 0.4896, P = 0.0078) (Figure 7c ). Figure 6 . Homozygosity for the ATG16L1 T300A-encoding gene variant is associated with increased (LPS+ATP)-induced IL-1β production. (a and b) IL-1β (left), IL-6 (middle), and TNFα (right) assayed by enzyme-linked immunosorbent assay (ELISA) in clarified tissue culture supernatants from (LPS+ATP)-stimulated PBMCs, stratified for the ATG16L1 CD susceptibility SNP (rs2241880) genotype from (a) control subjects (black circles) and subjects with ileal CD (open squares) and (b) a second cohort of healthy control subjects. (c) IL-1β mRNA expression, normalized to β-actin gene expression, in (LPS+ATP)-stimulated PBMCs from healthy control subjects stratified for the ATG16L1 CD susceptibility SNP (rs2241880) genotype was determined by qRT-PCR. (d) IL-1β assayed by ELISA in clarified tissue culture supernatants from (LPS+ATP)-stimulated wild type (SHIP +/+ ) bone marrow macrophages that were untreated or incubated in starvation medium for 4 h before stimulation. (e) IL-1β assayed by ELISA in clarified tissue culture supernatants from (LPS+ATP)-stimulated THP-1 cells that were untreated or incubated in starvation medium for 4 h before stimulation, and in the absence or presence of nsRNA or siRNA targeting ATG16L1. In (a), each symbol represents an individual subject (n = 13 control subjects, n = 8 subjects with ileal CD). In (a-c), horizontal lines indicate means ± s.e.m. In (b) and (c), n = 6 subjects per genotype. In (d) and (e), data represent the means ± s.e.m. for n = 4 or 3 independent experiments, respectively. *P o 0.05, **P o 0.01, NS = not significantly different (one-way ANOVA with Bonferroni correction for multiple pairwise comparisons between genotypes).
Taken together, our data suggest that low SHIP expression contributes to increased IL1B transcription and thereby regulates the level of IL-1β secreted by human PBMCs.
IL-1β is an important cytokine in IBD. It is secreted from intestinal tissues and macrophages isolated from patients with IBD and IL-1β levels correlate with disease severity. [41] [42] [43] [44] IL-1β antagonism has been used effectively to treat some genetically defined forms of very early onset IBD 45 and may be more broadly applicable for the treatment of subgroups of IBD. To our knowledge, this is the first mechanistic insight into the regulation of IL1B transcription by autophagy and ATG16L1. Evidence suggests that autophagy modulates the inflammatory response by regulating pro-inflammatory IL-1β production in both mice and in humans. 46 In mice, autophagy blocks inflammasome activation by degrading cytosolic danger-associated molecular patterns (DAMPs) that activate inflammasomes, mitochondrial DNA or reactive oxygen species, 47 or by degrading inflammasomes/ caspase-1 48 or pro-IL-1β directly. 49 Thus, in mice, inhibition or defects in autophagy may lead to uncontrolled IL-1β production by increasing inflammasome activation, rather than by affecting IL1B transcription. [47] [48] [49] [50] [51] In contrast, in humans, increased IL-1β production in people with the ATG16L1 risk variant has been attributed to increased ILIB transcription. 18 Our human data are consistent with a model in which autophagy upregulates SHIP, and SHIP limits the transcription of IL1B.
In summary, we have demonstrated that SHIP mRNA expression and activity are reduced in subjects with ileal CD and are also lower in subjects, who are homozygous for the ATG16L1 CDassociated gene variant, in two independent human cohorts. SHIP is upregulated during autophagy and SHIP protein levels and induction are compromised in subjects, who are homozygous for the ATG16L1 CD-associated gene variant. IL-1β production and IL1B transcription are higher in PBMCs from subjects, who are homozygous for the ATG16L1 CD-associated gene variant. Importantly, SHIP mRNA expression is inversely related to IL-1β production and IL1B transcription induced in PBMCs from our subject cohorts. Our results identify SHIP as a critical link between the ATG16L1 CD-associated gene variant and increased IL1B transcription, which may contribute to the increased risk of developing intestinal inflammation in subjects who carry the ATG16L1 CD-associated gene variant. Future studies will focus on examining the impact of additional autophagy-related CD susceptibility SNPs on autophagy, SHIP mRNA expression and activity, and IL-1β production, to determine whether we can identify a subpopulation of people with CD, who may be amenable to treatment with IL-1β or IL-1 receptor antagonists.
MATERIALS AND METHODS

Subjects with ileal CD and control subjects
This study was performed in accordance with ethical guidelines approved by the University of British Columbia Research Ethics Boards (H09-01826). Written informed consent was obtained from all subjects. Patients seen in the Division of Gastroenterology at BC Children's Hospital and scheduled for colonoscopy were recruited into the study. None of the patients had been previously diagnosed or treated for IBD or other inflammatory disease. Four biopsies were taken from the ileum and colon at sites of inflammation, which were adjacent to tissues harvested for pathological assessment in patients diagnosed with CD. Similar sites were biopsied in control subjects. During the procedure, peripheral blood was drawn from the site of intravenous insertion. The diagnosis of CD with inflammation in the ileum, or absence of IBD, was based on colonoscopy and pathological assessment. Twenty-one subjects were included in the analyses, eight patients diagnosed with CD with ileal inflammation and 13 subjects with no IBD. Biopsy samples and PBMCs isolated from peripheral blood were either stored in RNAlater (Invitrogen, Burlington, ON, Canada) for gene expression analyses, or used immediately for biochemical and immunological assays. All analyses were performed on participants before diagnosis.
Healthy control subjects
Experiments were performed in accordance with ethical guidelines and with approval by the University of British Columbia Research Ethics Boards (H04-0534). Written informed consent was obtained from all subjects. Isolated PBMCs were used for analyses. Eighteen subjects, six from each ATG16L1 genotype, were used for analyses. PBMCs were isolated from peripheral blood and DNA was stored for genotyping, or fresh PBMCs were used for biochemical and immunological assays. All analyses were performed on participants before stratification by genotype.
Cell isolation and derivation conditions
PBMCs were isolated from whole blood by density gradient centrifugation using Ficoll-Paque PLUS (GE Healthcare, Piscataway, NJ, USA). Cells were washed and resuspended at a density of 0.5 × 10 6 cells ml − 1 in Iscove's Modified Dulbecco's Medium supplemented with 10% fetal bovine serum for assays. DNA was prepared for genotyping using the QiaAMP DNA blood mini kit, as per the manufacturer's instructions (Qiagen, Toronto, ON, Canada), and fresh PBMCs were used for analyses of gene expression, SHIP activity, autophagy and cytokine production. THP-1 cells, from the ATCC and free of mycoplasma contamination, were maintained in RPMI 1640, 10% FCS, and pen/strep. Cells (0.5 × 10 6 cells ml − 1 ) were differentiated for 16 h in 20 ng ml − 1 PMA for use in autophagy assays.
Bone marrow macrophages were derived from bone marrow aspirates of femura and tibiae from wild-type (SHIP +/+ ) and SHIP-deficient mice (SHIP − / − ), as previously described. 23 Briefly, following adherence depletion, bone marrow aspirates were resuspended in Iscove's Modified Dulbecco's Medium, 10% fetal bovine serum, pen/strep at a concentration of 0.5 × 10 6 cells ml − 1 for 10 days in the presence of 5 ng ml − 1 MCSF (StemCell Technologies, Vancouver, BC, Canada) with complete media changes at days 4 and 7. At day 10, macrophages were 4 95% F4/80 + and Mac-1 + .
Genotyping the ATG16L1 CD susceptibility SNP, rs2241880
Stored DNA samples were used to genotype the ATG16L1 SNP, rs2241880, using a commercially available Taqman assay (C_9095577_20; Applied Biosystems, Burlington, ON, Canada). SNPs were deemed acceptable for analysis if they had call rates 495% and frequencies did not deviate from Hardy-Weinberg equilibrium (Po0.05).
Gene expression analyses
Murine bone marrow macrophages, human tissue sections, or PBMCs were stored in RNAlater at − 20°C. RNA was prepared using the either Qiagen RNeasy Mini Kit (Qiagen) or NucleoSpin RNA II Total RNA Isolation Kit according the manufacturer's protocol (Macherey-Nagel, Bethlehem, PA, USA). RNA concentration was measured using the NanoDrop 1000 Spectrophotometer. RNA was reverse transcribed using Superscript II (Invitrogen).
For analysis of murine SHIP (Inpp5d) and β-actin (ActB) gene expression, qPCR was performed using 2 × SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) on the CFX96 C1000 Thermal Cycler (Bio-Rad Laboratories, Mississauga, ON, Canada). Primers were from Bio-Rad Laboratories, catalogue number 100-25636, with unique identifiers qMmuCED0045767 (Inpp5D), and qMmuCED0027505 (ActB).
For analysis of human SHIP (INPP5D), ATG16L1 (ATG16L1), CD45 (PTPRC), and β-actin (ACTB) gene expression, qPCR was performed using 2 × SYBR Green PCR Master Mix (Applied Biosystems) on the CFX96 C1000 Thermal Cycler (Bio-Rad Laboratories). Primers were from Bio-Rad Laboratories, catalogue number 100-25636, with unique identifiers qHsaCID0014830 (INPP5D), qHsaCID009284 (ATG16L1), qHsaCED0038908 (PTPRC) and qHsaCED0036269 (ACTB).
For analysis of human IL-1β gene expression (IL1B), qPCR was performed using the AB Applied Biosystems Taqman Universal Master Mix II (Invitrogen). Primer sequences used were as follows:
ILIB (IL-1β) forward 5′-ATGCACCTGTACGATCACTG-3′ ILIB (IL-1β) reverse 5′-ACAAAGGACATGGAGAACACC-3′ ILIB (IL-1β) probe 5′-/56-FAM/CCAGGGACA/ZENGGATATGGAGCAACA/ 3IABkFQ/-3′ ACTB forward 5′-ACCTTCTACAATGAGCTGCG-3′ ACTB reverse 5′-CCTGGATAGCAACGTACATGG-3′ ACTB probe 5′-/56-FAM/ATCTGGGTC/ZEN/ATCTTCTCGCGGTTG/3IABkFQ/-3′
SHIP activity assays
To quantify SHIP activity, SHIP was immunoprecipitated with anti-human SHIP1 antibody (N-1, sc6244; Santa Cruz Biotechnology, Santa Cruz, CA, USA), as described previously. 32 Briefly, intestinal biopsy sections were weighed or PBMCs were counted and immunoprecipitates were prepared. Substrate, 100 μM IP 4 (Echelon Biosciences, Salt Lake City, UT, USA) was incubated with immunoprecipitates for 20 min and the reaction was stopped by heating samples to 80°C for 5 min. Inorganic phosphate released was detected using Malachite Green (Echelon Biosciences) and absorbance was read at 650 nm and compared with a standard curve.
Autophagy induction and western blot analyses
Autophagy was induced in murine macrophages, THP-1 cells, or PBMCs by starvation. Media was removed and cells were washed twice and resuspended in Hanks Balanced Salt Solution for 4 h. Cells, 2.5 × 10 6 murine bone marrow-derived macrophages or 0.5 × 10 6 THP-1 cells or PBMCs, were harvested for western immunoblot analysis. In THP-1 cells, ATG16L1 was knocked down using Stealth RNAi (HSS182825) or a nonsilencing control RNAi (Life Technologies, Burlington, ON, Canada). Stealth RNAi or non-silencing control RNAi was transfected into THP-1 cells using Lipofectamine 2000, according to the manufacturer's protocol (Life Technologies). Whole cell lysates were subjected to SDS-PAGE and transferred onto PVDF for immunodetection, as described previously. 52 The following antibodies were used for analyses: anti-mouse SHIP (P1C1, Santa Cruz Biotechnology), anti-mouse and -human LC3 (NB100-2220, Novus Biologicals, Oakville, ON, Canada), anti-mouse GAPDH (Fitzgerald Industries International, Acton, MA, USA), anti-human ATG16L1 (Abcam, Toronto, ON, Canada), anti-human SHIP (N1, Santa Cruz Biotechnology), and anti-human GAPDH (eBiosciences, San Diego, CA, USA). Densitometry was performed using ImageJ software (National Institute of Health, Bethesda, MD, USA).
Cell stimulations for cytokine production and analyses
Murine bone marrow macrophages or PBMCs were plated at a density of 0.5 × 10 6 cells ml − 1 of complete medium. For ILIB gene expression analysis, PBMCs were unstimulated or stimulated with 10 ng ml − 1 of LPS (E. coli serotype 127:B8, Sigma Aldrich, St Louis, MO, USA) for 3 h, and RNA was isolated and gene expression measured as described earlier.
For IL-1β cytokine production, cells were unstimulated or stimulated with 10 ng ml − 1 LPS for 5 h, 5 mM ATP for 1 h or LPS for 4 h with the addition of ATP for a final 1 h. After incubation (5 h in total), clarified cell supernatants were analyzed by enzyme-linked immunosorbent assay. For TNFα and IL-6 production, cells were unstimulated or stimulated with 10 ng ml − 1 LPS for 24 h. Cytokine measurements were performed on clarified, cell-free tissue culture supernatants by enzyme-linked immunosorbent assay, according to the manufacturers' instructions. Enzyme-linked immunosorbent assay kits for murine IL-1β, human IL-β, TNFα and IL-6 were from BD Biosciences (Mississauga, ON, USA).
Statistical analyses
Unpaired two-tailed Student's t-tests, one-way ANOVA, and linear regression analyses were performed using GraphPad Prism version 5 software (La Jolla, CA, USA). For multiple comparisons, the Bonferroni correction was applied. Differences were considered significant at Po0.05.
